Skeletal Muscle Channelopathies
Gene: SLC1A3Comment on list classification: Leaving as green for consistency with the GMS Skeletal muscle channelopathy panel (panel 542).Created: 20 Jul 2021, 2:07 p.m. | Last Modified: 20 Jul 2021, 2:07 p.m.
Panel Version: 1.37
Comment when marking as ready: Marked as green after discussion with expert reviewer Dr Emma MatthewsCreated: 21 Feb 2017, 12:49 p.m.
this is not a Skeletal Muscle Channelopathies geneCreated: 10 Jan 2017, 3:49 p.m.
Is on the Brain Channel NGS Panel in the UCLH National Hospital for Neurology and Neurosurgery & Institute of Neurology (NHNN) Neurogenetics genetic testing manual, I am therefore unsure whether this should be included on this panel.Created: 10 Jun 2016, 2:52 p.m.
Gene: slc1a3 has been classified as Green List (High Evidence).
Promoted 22/02/2017 after curation discussion and further review with members of the Genomics England curation team.
This gene has been classified as Green List (High Evidence).
This gene has been classified as Green List (High Evidence).
This gene has been classified as Amber List (Moderate Evidence).
This gene has been classified as Amber List (Moderate Evidence).
Model of inheritance for gene SLC1A3 was changed to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
SLC1A3 was added to Skeletal Muscle Channelopathiespanel. Sources: Illumina TruGenome Clinical Sequencing Services
SLC1A3 was added to Skeletal Muscle Channelopathiespanel. Sources: Radboud University Medical Center, Nijmegen